Position in NUVB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,798,094
+$494,445 QoQ
Shares Held
316,566
+4.2% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. NUVB ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,798,094 | 316,566 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,303,649 | 303,881 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,761,373 | 308,189 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,147,688 | 310,186 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $580,097 | 297,486 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $439,868 | 249,925 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $701,721 | 263,805 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $610,017 | 266,383 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $761,941 | 260,939 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $755,482 | 207,550 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $317,548 | 210,297 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $287,089 | 214,246 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $720,376 | 400,209 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $285,073 | 171,731 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $334,711 | 174,329 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $384,899 | 171,830 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $526,172 | 162,399 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $855,544 | 162,651 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,279,054 | 150,477 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $520,627 | 52,377 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $322,563 | 34,647 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||